Delivery Order SPE2DB20D3103-SPE2DB25FP6K8
- Not listed
- The Defense Logistics Agency awarded a $2,536.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Alphagan P 0.15% eye drops (10 mL), with an ultimate completion date of September 8, 2025. This competitive delivery order, issued on September 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alphagan P 0.1% eye drops, a prescription medication used to treat glaucoma. The contract has a firm fixed price of $5,040.91 and a completion date of November 25, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,789.13, is for the delivery of Alphagan P 0.1% eye drops, with a completion date of July 5, 2024. This contract is a firm fixed-price delivery order, and it is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a larger Indefinite...
- This federal contract award is for the delivery of ALPHAGAN P 0.15% eye drops in 5mL units. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This is a firm fixed price delivery order contract with a ceiling value of $1,187.20 and a period of performance through March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ALPHAGAN P 0.15% eye drops in 10ml bottles. The contract has a ceiling value of $7,471.82 and a completion date of September 3, 2024. It is a firm fixed-price contract, and there is no set-aside designation. Amerisourcebergen is the prime contractor, and the contract is part of a larger Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 5 milliliter bottles of Alphagan P 0.1% eye drops. The $1,161.41 delivery order is for the period ending on December 27, 2023. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and related...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alphagan P 0.15% eye drops, a prescription medication, with a ceiling value of $1,091.97. The contract type is firm-fixed price and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,148.11 firm fixed-price delivery order is for the supply of Alphagan P 0.15% eye drops, with a completion date of February 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,154.52, is for the supply of ALPHAGAN P 0.15% eye drops in 5 ml containers. The contract has an ultimate completion date of July 5, 2023 and does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $1,190.07, is for the supply of Alphagan P 0.15% eye drops. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6K8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Alphagan P 0.1% ophthalmic drops in 15ml quantities, with a ceiling value of $1,034.90. This competitively awarded, non-set-aside firm fixed price delivery order is scheduled for completion by July 28, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, delivers a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare systems and other federal customers. This delivery order for ophthalmic medication aligns with the company's extensive federal contract activity supplying medications across multiple therapeutic domains, including specialty drugs, generics, vaccines, and medical devices to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the DLA's global pharmaceutical support program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/25/25 |